Oliver A. Cornely

Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

Oliver A. Cornely, Johan Maertens, Drew J. Winston et al. · New England Journal of Medicine · 2007 · 1.8K citations · Full text

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Andrew J. Ullmann, José María Aguado, David W. Denning et al. · Clinical Microbiology and Infection · 2018 · 1.5K citations · Full text

Diagnostic Mycology, Diagnosis, Pathology +6

ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

Oliver A. Cornely, Matteo Bassetti, Thierry Calandra et al. · Clinical Microbiology and Infection · 2012 · 1.2K citations · Full text

Diagnostic Mycology, Translational Medicine, Non-neutropenic Adult Patients +6

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Johan Maertens, Issam Raad, Kieren A. Marr et al. · The Lancet · 2015 · 938 citations

Antifungal Agent, Isavuconazole Versus Voriconazole, Antifungal Agents +7

Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia

Thomas J. Walsh, Hedy Teppler, Gerald R. Donowitz et al. · New England Journal of Medicine · 2004 · 917 citations · Full text